1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 8-29-22 at 4:00pm, regional office conducted an informal meeting with facility to discuss recent citations issued and additional concerns. This meeting was held virtually via Teams Meeting. Present at the meeting were Licensing Program Manager (LPM) Liza King, Licensing Program Analyst (LPA) Michael Bilger, LPA Renee Campbell, LPA Kesha Lewis, Department of Healthcare Services (DHCS) representatives Andrew Chen and Kevin Phomthevy, Ombudsman Kathryn Thomas, Convenant Care representative Lisa Clayton, Wagner Heights Nursing and Rehab Administrator Maxine Niel, Administrator Charles White, and Interim Administrator Belinda Guzman. Topics in this meeting included the following: (1) Reporting Requirements, (2) Plan of Operation, (3) Staffing, (4) Staff Training, (5) Infection Control Safety, (6) Incidental Medical and Dental Care, (7) Physical Plant, (8) Eviction, (9) Care and Supervision.
On 3-4-22, and 6-24-22, citations was issued to facility for reporting requirements, section 87211(a)(1)(B) and section 87211(a)(1) due to not reporting an infectious disease and an elopement episode respectively. Additionally, on 6-24-22, a citation was issued to facility for reporting requirements section 87211(a)(1) due to not informing a responsible party of an elopement episode on 5-15-22. Administrator is aware of timeline for reporting requirements and associated regulation, and has developed a plan in place to ensure compliance going forward.
On 4-13-22 citations were issued to facility for personal rights, section 87468.1(a)(2) due to facility not ensuring a COVID-19 infection symptom screening procedure and sign in policy. Additionally, a citation was issued to facility for personal rights Section 87468(c) for not posting personal rights, discrimination notice, or complaint information prominently. Facility now has a screening process in place which includes a staff member designated to screen all visitors at the front which includes temperature checks and COVID-19 symptom screening questions.
{Cont. on 809C}
|